Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

An acute bleomycin inflammatory and fibrotic mouse model of morphea is dependent upon CXCL9 and CXCR3

View ORCID ProfileJillian M. Richmond, Dhrumil Patel, Tomoya Watanabe, View ORCID ProfileColton J. Garelli, Madhuri Garg, Karen Dresser, April Deng, Carol A. Feghali-Bostwick, View ORCID ProfileJohn E. Harris, Heidi Jacobe
doi: https://doi.org/10.1101/19000844
Jillian M. Richmond
1Department of Dermatology, UMass Medical School, Worcester, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jillian M. Richmond
Dhrumil Patel
1Department of Dermatology, UMass Medical School, Worcester, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoya Watanabe
2Division of Rheumatology & Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colton J. Garelli
1Department of Dermatology, UMass Medical School, Worcester, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Colton J. Garelli
Madhuri Garg
1Department of Dermatology, UMass Medical School, Worcester, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen Dresser
3Department of Pathology, UMass Medical School, Worcester, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
April Deng
3Department of Pathology, UMass Medical School, Worcester, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol A. Feghali-Bostwick
2Division of Rheumatology & Immunology, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John E. Harris
1Department of Dermatology, UMass Medical School, Worcester, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John E. Harris
Heidi Jacobe
4Department of Dermatology, UT Southwestern Medical Center, Dallas, TX, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Heidi.Jacobe@UTSouthwestern.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Morphea, or localized scleroderma, is characterized by an inflammatory phase followed by cutaneous fibrosis, which may lead to disfigurement and/or disability. Previous work from our group showed that the CXCR3 ligands CXCL9 and CXCL10 are highly upregulated in lesional skin of morphea patients. Here, we used an acute inflammatory and fibrotic bleomycin mouse model of morphea to examine the role of the CXCR3 chemokine axis in pathogenesis. We first characterized which cells produce the CXCR3 ligands in the skin using the Reporter of Expression of CXCR3 ligands mouse (REX3). We found that fibroblasts contribute the bulk of CXCL9 and CXCL10, whereas endothelial cells are key dual chemokine producers. Macrophages, which have high MFI of chemokine expression, upregulated CXCL9 production over time, fibroblasts CXCL10 production, and T cells dual chemokine expression. To determine whether bleomycin treatment could directly induce expression of these chemokines, we treated cultured REX3 mouse dermis monolayers in vitro with bleomycin or IFNγ with TNF and found that bleomycin could induce low amounts of CXCL9 directly in fibroblasts, whereas the cytokines were required for optimal CXCL9 and CXCL10 production. To determine whether these chemokines are mechanistically involved in pathogenesis, we induced fibrosis in CXCL9, CXCL10, or CXCR3 deficient mice and found that fibrosis is dependent on CXCL9 and CXCR3. Addition of recombinant CXCL9, but not CXCL10, to cultured mouse fibroblasts induces collagen 1a1 mRNA expression, indicating the chemokine itself can contribute to fibrosis. Taken together, our studies provide evidence that acute intradermal bleomycin administration in mice can model inflammatory morphea, and that CXCL9 and its receptor CXCR3 are mechanistically involved in pathogenesis.

One Sentence Summary CXCL9 drives acute morphea pathogenesis in mice.

Competing Interest Statement

JMR and JEH are inventors on patent application #62489191, "Diagnosis and Treatment of Vitiligo" which covers targeting IL-15 and Trm for the treatment of vitiligo. JEH is scientific founder of Villaris Therapeutics, Inc, which is focused on developing treatments for vitiligo. JMR and JEH are inventors on patent application #15/851,651, "Anti-human CXCR3 antibodies for the Treatment of Vitiligo" which covers targeting CXCR3 for the treatment of vitiligo.

Funding Statement

Supported by a Calder Research Scholar Award from the American Skin Association, a Career Development Award from the Dermatology Foundation (to J.M.R.), NIH awards AR09114 and AR07302 (to J.E.H.). Flow cytometry and confocal microscopy equipment used for this study is maintained by the UMMS Flow Cytometry Core Facility and Morphology Core Facility, and tissue sectioning and pathology services are maintained by the UMMS DERC Morphology Core.

Author Declarations

All relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

NA

Any clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.

NA

I have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Co-first authors

Data Availability

Primary data are available upon request. Materials (REX3 mice and CXCL9-deficient mice) were obtained through MTAs with Massachusetts General Hospital and the National Institutes of Health.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 28, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
An acute bleomycin inflammatory and fibrotic mouse model of morphea is dependent upon CXCL9 and CXCR3
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
An acute bleomycin inflammatory and fibrotic mouse model of morphea is dependent upon CXCL9 and CXCR3
Jillian M. Richmond, Dhrumil Patel, Tomoya Watanabe, Colton J. Garelli, Madhuri Garg, Karen Dresser, April Deng, Carol A. Feghali-Bostwick, John E. Harris, Heidi Jacobe
medRxiv 19000844; doi: https://doi.org/10.1101/19000844
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
An acute bleomycin inflammatory and fibrotic mouse model of morphea is dependent upon CXCL9 and CXCR3
Jillian M. Richmond, Dhrumil Patel, Tomoya Watanabe, Colton J. Garelli, Madhuri Garg, Karen Dresser, April Deng, Carol A. Feghali-Bostwick, John E. Harris, Heidi Jacobe
medRxiv 19000844; doi: https://doi.org/10.1101/19000844

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Dermatology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (50)
  • Cardiovascular Medicine (451)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5258)
  • Forensic Medicine (3)
  • Gastroenterology (195)
  • Genetic and Genomic Medicine (757)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (698)
  • Health Policy (358)
  • Health Systems and Quality Improvement (223)
  • Hematology (99)
  • HIV/AIDS (163)
  • Infectious Diseases (except HIV/AIDS) (5867)
  • Intensive Care and Critical Care Medicine (361)
  • Medical Education (104)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (764)
  • Nursing (43)
  • Nutrition (130)
  • Obstetrics and Gynecology (142)
  • Occupational and Environmental Health (231)
  • Oncology (479)
  • Ophthalmology (152)
  • Orthopedics (38)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (862)
  • Public and Global Health (2011)
  • Radiology and Imaging (348)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (285)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (76)
  • Surgery (109)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)